Additionally, our analysis shows that siRNA-induced osteopontin inhibition results in reduced clonogenic survival and migration of soft tissue sarcoma and breast cancer cell lines (Hahnel et al., manuscript submitted). Here, SPP1 is linked to soft tissue sarcoma.